Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Top AstraZeneca investor backs Soriot and his 'golden hello'
Fierce Pharma
Monday, April 22, 2013 - 11:19am
tags:
Pascal Soriot, executive pay, AstraZeneca
Targacept moving forward with trials for schizophrenia treatment
Winston-Salem Journal, NC
Monday, April 22, 2013 - 11:16am
tags:
schizophrenia, Targacept, TC-5214
5 Must-Watch Earnings Reports in the Health-Care Sector This Week
Motley Fool
Monday, April 22, 2013 - 11:14am
tags:
earnings, Eli Lilly, Wellpoint, Biogen Idec, Celgene, Alexion
GSK,Theravance announce regulatory submission for Anoro Ellipta in Japan
Reuters
Monday, April 22, 2013 - 11:13am
tags:
Anoro Ellipta, Japan, COPD, GSK, Theravance
Amgen Reporting Earnings In Wake Of Big Stock Run
Investors.com
Monday, April 22, 2013 - 11:11am
tags:
earnings, Amgen
FDA Approves Neuralstem To Treat Final Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder
Yahoo
Monday, April 22, 2013 - 11:05am
tags:
FDA, Neuralstem, NSI-189, major depressive disorder
Biogen: Will it Miss Earnings Again?
Yahoo/Zacks
Monday, April 22, 2013 - 11:04am
tags:
earnings, Biogen
Warner Chilcott Announces FDA Approval of New Oral Contraceptive
Yahoo
Monday, April 22, 2013 - 10:58am
tags:
drug approvals, Warner Chilcott, oral contraceptives, FDA, Minastrin 24 FE
Novartis AG's New Medicine Approval Looks Interesting
Seeking Alpha
Monday, April 22, 2013 - 10:57am
tags:
Novartis, Simbrinza, primary open-angle glaucoma, ocular hypertension
Merck, Bristol-Myers will test hepatitis C regimen
Yahoo/AP
Monday, April 22, 2013 - 10:54am
tags:
hepatitis C, Merck, Bristol-Myers Squibb, MK-5172, daclatasvir
Amarin's Fish Oil Pill Faces Even More Exclusivity Risks
TheStreet.com
Monday, April 22, 2013 - 10:53am
tags:
Amarin, Vascepa, exclusivity
Biogen's MS Pill Roars Out Of Launch Gate
TheStreet.com
Monday, April 22, 2013 - 10:52am
tags:
Biogen, drug launches, MS, multiple sclerosis, Tecfidera, Gilenya, Novartis
AstraZeneca bets on nanotech with Bind Therapeutics deal
Reuters
Monday, April 22, 2013 - 10:26am
tags:
Nanotechnoogy, Bind Therapeutics, AstraZeneca
Reckitt Benckiser Repeats Growth Targets as Sales Rise on Flu
Bloomberg
Monday, April 22, 2013 - 10:25am
tags:
earnings, Reckitt Benckiser
Elan rejects Royalty bid as grossly undervaluing its prospects
Reuters
Monday, April 22, 2013 - 10:24am
tags:
Royalty Pharma, Elan, M&A
Lilly And Sanofi CEOs Take Two Very Different R&D Paths In Alzheimer's Disease
Forbes
Monday, April 22, 2013 - 10:23am
tags:
Pharma CEOs, Sanofi, Eli Lilly, Alzheimer's disease, R&D, Chris Viehbacher
Russia blocks Abbott Laboratories - Petrovax merger
domain-b
Sunday, April 21, 2013 - 10:44am
tags:
Abbott Laboratories, Petrovax, M&A
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Sunday, April 21, 2013 - 10:42am
tags:
JNJ, Bristol-Myers Squibb, Watson Pharmaceuticals, Repros Therapeutics
Drug Stocks on Citi's Dividend Buy List
Motley Fool
Sunday, April 21, 2013 - 10:24am
tags:
Pfizer, Merck, Bristol-Myers Squibb
An Open Letter To The PhRMA CEO On Pharma's Image
Forbes
Sunday, April 21, 2013 - 10:23am
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.